These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10629405)

  • 1. Heparins in diabetic microangiopathy: rationale and preliminary clinical results.
    van Der Woude FJ
    Haemostasis; 1999 Dec; 29 Suppl S1():61-7. PubMed ID: 10629405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus and microcirculation. Significance of diabetic angiopathy for the prognosis and course of diabetes mellitus, possibilities and bases of angiologic therapy].
    Semler P; Werner U
    Fortschr Med; 1976 Mar; 94(7):354-7. PubMed ID: 964891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of heparin on vascular dysfunction in diabetic rats.
    Oturai PS
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):411-4. PubMed ID: 10386230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
    McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
    Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic microangiopathy and urinary glycosaminoglycans.
    Kahaly G; Hansen C; Otto E; Förster G; Beyer J; Hommel G
    Exp Clin Endocrinol Diabetes; 1997; 105(3):145-51. PubMed ID: 9228510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
    van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
    Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
    J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of enalapril on urinary glycosaminoglycan, heparan sulphate and microalbuminuria in type II diabetic patients.
    Zuhal Parildar Tiujen Tanyalcin Sevkiu Cetiunkalp Mehmet Tuzun Fatma Kutay
    Biomarkers; 1999; 4(5):351-60. PubMed ID: 23902355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of proinflammatory cytokines in the development and progression of micro- and macroangiopathies in patients with type 2 diabetes mellitus].
    Nelaeva AA; Khasanova IuV; Khobotova ES
    Angiol Sosud Khir; 2013; 19(3):9-13. PubMed ID: 24300485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lung microangiopathy in diabetes].
    Kuziemski K; Górska L; Jassem E; Madej-Dmochowska A
    Pneumonol Alergol Pol; 2009; 77(4):394-9. PubMed ID: 19722145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative treatment of diabetic microangiopathy and macroangiopathy].
    Smahelová A
    Cas Lek Cesk; 2009; 148(2):72-5, 77. PubMed ID: 19637441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients.
    Jensen T; Deckert T
    Horm Metab Res Suppl; 1992; 26():68-70. PubMed ID: 1490695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is diabetic microangiopathy genetically heterogeneous? HLA and diabetic nephropathy.
    Barbosa J
    Horm Metab Res Suppl; 1981; 11():77-80. PubMed ID: 6947952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic microangiopathy in patients with cystic fibrosis.
    Sullivan MM; Denning CR
    Pediatrics; 1989 Oct; 84(4):642-7. PubMed ID: 2780126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of microangiopathy in type 1 diabetes mellitus. A review.
    Borch-Johnsen K
    Diabete Metab; 1993; 19(1 Pt 2):133-7. PubMed ID: 8314416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of calcium channel blocker therapy in diabetes mellitus.
    Savage S; Miller LA; Schrier RW
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S19-24. PubMed ID: 1723450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.